10 - 11 March 2020

4th Annual MarketsandMarkets Bioprocessing of Advanced Cellular Therapies & Regenerative Medicine Congress

London - UK

Devising the effective manufacturing and quality control methods of cell therapies

Regenerative therapies are proving its acceptance in potential of cell-based therapies for chronic disorders. Since our past three editions, our aim through this conference is to provide illustrative approach to recent developments in technologies of bioprocessing of cellular therapies, to process development and addressing qualitative and regulatory hurdles.

In the 4th edition of MarketsandMarkets Bioprocessing of Advanced Cellular Therapies & Regenerative Medicine we would be focusing on the pre-clinical, manufacturing, clinical and regulatory aspects of cell therapies and regenerative medicine. The special impact would be laid on tissue engineering, car-T cell-based immunotherapies, automated manufacturing, allogenic therapies, with the aspects of hurdles in supply chain management and regulatory affairs.

WHAT TO EXPECT
Who should attend

VPs, heads, directors, managers, leaders, engineers, scientists, working in 

Cell Culture | Cell Therapy | Upstream Processing | Stem Cell therapy | Process Development | Bioprocessing | Downstream Processing | Quality Control | Bioengineering | Translational Sciences

Academia: Universities and Research Institute 

Scientists/Professors/Researchers/Project leaders

Key Highlights
  • Stem cell therapy
  • Stem cell transplantation
  • Clinical translation of cell therapy
  • Conventional Car-T cell delivery
  • Allogenic Car-T cell therapy
  • Quality control in manufacturing of cell therapy
  • Supply chain management
  • Regulatory and reimbursement issues
CONFERENCE AGENDA
CONFERENCE SPEAKERS
Advisors
Petter Bjorquist

Petter Bjorquist

CEO
Verigraft

Petter Bjorquist

CEO
Verigraft
Speakers
Shailendra Singh (Shelly)

Shailendra Singh (Shelly)

Chief Operating Officer
MarketsandMarkets

Shailendra Singh (Shelly)

Chief Operating Officer
MarketsandMarkets
Petter Bjorquist

Petter Bjorquist

CEO
Verigraft

Petter Bjorquist

CEO
Verigraft
Ryan Guest

Ryan Guest

Director Cell Production
Immetacyte Ltd

Ryan Guest

Director Cell Production
Immetacyte Ltd
Damian Marshall

Damian Marshall

Director New Technology
Cell and Gene Therapy Catapult

Damian Marshall

Director New Technology
Cell and Gene Therapy Catapult
John Bridgeman

John Bridgeman

Director of Cell Therapy Research
Immetacyte Ltd

John Bridgeman

Director of Cell Therapy Research
Immetacyte Ltd
Susan Kimber

Susan Kimber

Professor of Stem cell & Developmental Biology
The University of Manchester

Susan Kimber

Professor of Stem cell & Developmental Biology
The University of Manchester
David Gilham

David Gilham

Vice President Research & Development
Celyad

David Gilham

Vice President Research & Development
Celyad
Karin Jennbacken

Karin Jennbacken

Team Leader, Heart Failure in vitro team
AstraZeneca

Karin Jennbacken

Team Leader, Heart Failure in vitro team
AstraZeneca
SPONSORS
Silver
example-image

Eppendorf

Visiting Partners
example-image

3M Ireland Limited

PARTNERS
Supporting Association
MabDesign

MabDesign

Media Partners
example-image

Technology Networks

example-image

GEN

LOCATION
London - UK

Please contact us on events@marketsandmarkets.com to get the hotel booking link.

About the Hotel

For any queries regarding the hotel booking please write to us at events@marketsandmarkets.com

Hotel Booking Link

You will receive a link to book your accommodation via email once you are fully registered. (Please note that we do not authorize any 3rd party agencies (e.g. Exhibitors Housing Management) to book on our behalf and, occasionally, companies fraudulently try to represent us. If you are contacted by anyone other than us regarding your accommodation requirements for this event, please let us know immediately on events@marketsandmarkets.com

PAST EVENT GALLERY